Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-22-000892
Filing Date
2022-04-29
Accepted
2022-04-29 16:14:05
Documents
1
Period of Report
2022-04-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 10031
  Complete submission text file 0001593968-22-000892.txt   11480
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Issuer) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ANTARES PHARMA, INC. 707 EAGLEVIEW BOULEVARD, SUITE 414 EXTON PA 19341
Business Address
Wotton Paul K (Reporting) CIK: 0001300997 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35280 | Film No.: 22875581